Entering the era of precision medicine in pediatric oncology
Nat Med
.
2020 Nov;26(11):1684-1685.
doi: 10.1038/s41591-020-1119-6.
Authors
Djihad Hadjadj
1
,
Shriya Deshmukh
2
,
Nada Jabado
3
4
5
6
Affiliations
1
Department of Human Genetics, McGill University, Montreal, Canada.
2
Department of Experimental Medicine, McGill University, Montreal, Canada.
3
Department of Human Genetics, McGill University, Montreal, Canada. nada.jabado@mcgill.ca.
4
Department of Experimental Medicine, McGill University, Montreal, Canada. nada.jabado@mcgill.ca.
5
Department of Pediatrics, McGill University, Montreal, Canada. nada.jabado@mcgill.ca.
6
The Research Institute of the McGill University Health Centre, Montreal, Canada. nada.jabado@mcgill.ca.
PMID:
33077957
DOI:
10.1038/s41591-020-1119-6
No abstract available
Publication types
Comment
MeSH terms
Child
Epigenome
Humans
Medical Oncology
Neoplasms* / drug therapy
Neoplasms* / genetics
Precision Medicine*
Transcriptome